Treatment Settings and Outcomes with Regorafenib and Trifluridine/Tipiracil at Third-Line Treatment and beyond in Metastatic Colorectal Cancer: A Real-World Multicenter Retrospective Study.
Saved in:
| Title: | Treatment Settings and Outcomes with Regorafenib and Trifluridine/Tipiracil at Third-Line Treatment and beyond in Metastatic Colorectal Cancer: A Real-World Multicenter Retrospective Study. |
|---|---|
| Authors: | Signorelli, Carlo1 (AUTHOR) carlo.signorelli@asl.vt.it, Calegari, Maria Alessandra2 (AUTHOR), Basso, Michele2 (AUTHOR), Anghelone, Annunziato2 (AUTHOR), Lucchetti, Jessica3 (AUTHOR), Minelli, Alessandro3 (AUTHOR), Angotti, Lorenzo3 (AUTHOR), Zurlo, Ina Valeria4 (AUTHOR), Schirripa, Marta1 (AUTHOR), Chilelli, Mario Giovanni1 (AUTHOR), Morelli, Cristina5 (AUTHOR), Dell'Aquila, Emanuela6 (AUTHOR), Cosimati, Antonella6 (AUTHOR), Gemma, Donatello7 (AUTHOR), Ribelli, Marta8 (AUTHOR), Emiliani, Alessandra8 (AUTHOR), Corsi, Domenico Cristiano8 (AUTHOR), Arrivi, Giulia9 (AUTHOR), Mazzuca, Federica9 (AUTHOR), Zoratto, Federica10 (AUTHOR) |
| Source: | Current Oncology. Jun2023, Vol. 30 Issue 6, p5456-5469. 14p. 1 Diagram, 3 Charts, 4 Graphs. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
